R89P (p.Arg89Pro) variant of INS (Insulin)
R89P (p.Arg89Pro) in INS (Insulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of INS-related disorders; Diabetes mellitus, permanent neonatal 4; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.73 / 1. The record also includes population frequency data, published literature, and structural context.
R89P (p.Arg89Pro) variant details
- p.Arg89Pro
- rs28933985
- ClinGen CA123083
- ClinVar RCV000014315
- ExAC rs28933985
- Pathogenic
- INS-related disorders; Diabetes mellitus, permanent neonatal 4; not provided
- Missense
- Variant Prioritization Score for Impact Estimate 0.729
- REVEL 0.73
- ESM-1b 1.00
- AlphaMissense 0.86
- MetaLR 0.81
- MetaSVM 0.77
- CADD 25.20
- ClinVar: Pathogenic (Hyperproinsulinemia)
- EBI: Pathogenic (in HPRI)
- UniProt: Pathogenic (in HPRI)
- Most common in the Non-Finnish European population (allele frequency 4.5e-06)
- Structural context available
- Cited in: A novel point mutation in the insulin gene giving rise to hyperproinsulinemia. (PMID 9141561)